Functional and biomarker analyses of septic cardiomyopathy (SepCOR)

Functional and biomarker analyses of septic cardiomyopathy (SepCOR) - SepCOR

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032138

Enrollment

100

Registered

2023-06-26

Start date

2024-09-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Septic Cardiomyopathy

Interventions

Group 1: In 100 patients with sepsis, starting with the day of diagnosis (=day 1), a total of 5 echocardiographies will be performed. Additionally 4 blood samples of 30ml each will be drawn.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Consent by the consultant physician procedure ("Giessen model") or consent of the legal representative - Consent of the patient in case of existing capacity to give consent - Diagnosis of "sepsis" according to sepsis-3-definition within 24 h before study inclusion (presumed infection, SOFA-score = 2)

Exclusion criteria

Exclusion criteria: - Failure to meet inclusion criteria - Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Classic and novel echocardiographic methods are used to assess cardiac function.	—

Secondary

Measure	Time frame
Cardiac damage markers, experimental biomarkers, 30/90-day survival.	—

Countries

Germany

Contacts

Public ContactPatrick Rehn

Universitätsklinik Heidelberg, Klinik für Anästhesiologie

patrick.rehn@med.uni-heidelberg.de+4962215639435

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026